AHL Partners’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$474K Buy
+8,096
New +$459K 0.01% 1089
2017
Q3
Sell
-6,814
Closed -$524K 1311
2017
Q2
$524K Buy
6,814
+563
+9% +$42.1K 0.01% 932
2017
Q1
$467K Buy
+6,251
New +$454K 0.01% 969
2016
Q4
Sell
-10,316
Closed -$688K 1216
2016
Q3
$688K Buy
10,316
+5,206
+102% +$332K 0.03% 704
2016
Q2
$305K Buy
5,110
+742
+17% +$40.1K 0.02% 709
2016
Q1
$213K Sell
4,368
-1,114
-20% -$50.6K 0.01% 729
2015
Q4
$297K Sell
5,482
-2,387
-30% -$122K 0.02% 615
2015
Q3
$379K Buy
7,869
+2,050
+35% +$106K 0.06% 490
2015
Q2
$276K Buy
+5,819
New +$272K 0.01% 778

Other funds holding NUVA

AHL Partners's NUVA Position: Q4 2017 in Review

AHL Partners opened a new position in NuVasive, Inc. (NUVA) in Q4 2017: 8,096 shares worth $474K. The stake represents 0.01% of the portfolio and ranks #1089 among its holdings. This is a return to the name: AHL Partners previously reported a position in NUVA as recently as Q2 2017.

AHL Partners first reported a position in NUVA in Q2 2015 and has held it in 9 quarters since. The position peaked at $688K in Q3 2016. 269 funds tracked by Wall St. Rank hold NUVA as of Q4 2017.

  • AHL Partners held 8,096 shares of NuVasive, Inc. worth $474K as of Q4 2017.
  • NuVasive, Inc. was a new AHL Partners position in Q4 2017.
  • NuVasive, Inc. made up 0.01% of AHL Partners's portfolio in Q4 2017, its #1089 holding.
  • AHL Partners first reported a position in NuVasive, Inc. in Q2 2015 and has held it in 9 quarters since.
  • AHL Partners's NuVasive, Inc. position peaked at $688K in Q3 2016.
  • 269 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.